Article
Osteopontin as novel biomarker for reversibility of pressure overload induced left ventricular hypertrophy.
Biomarkers in medicine - 1 May 2020
Weber Andreas, L Büttner Annalena, Rellecke Philipp, Petrov Georgi, Albert Alexander, Sixt Stephan U, Lichtenberg Artur, Akhyari Payam
Abstract excerpt
Aim: The aim of this study was to evaluate the prognostic value of osteopontin (OPN) as a marker for left ventricular (LV) hypertrophy and its reversibility after surgical aortic valve replacement (SAVR). Patients & methods: Echocardiographic data and OPN plasma levels of 149 consecutive patients undergoing SAVR were obtained preoperatively and 3 months postoperatively. OPN was measured by Quantikine Human OPN...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
